Nanosensor electrical immunoassay for quantitative detection of NT-pro brain natriuretic peptide

Future Cardiology

Volumn 9, Issue 1, 2013, Pages 137-147

  Selvam, Anjan Panneer ^a   Prasad, Shalini ^a  

^a The University of Texas at Dallas   (United States)

Author keywords

biomarker; impedance biosensor; impedance spectroscopy; introduction; nanoporous membrane; NT proBNP

Indexed keywords

ALUMINUM OXIDE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC KIT; DOSE RESPONSE; ELECTRICAL IMMUNOASSAY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMPEDANCE; LIMIT OF DETECTION; NANOSENSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERUM;

ALUMINUM OXIDE; BIOLOGICAL MARKERS; DIELECTRIC SPECTROSCOPY; EQUIPMENT DESIGN; HUMANS; IMMUNOASSAY; MICRO-ELECTRICAL-MECHANICAL SYSTEMS; NANOPORES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84871581774     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.76     Document Type: Article

References (38)

1. Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J. Cardiothorac. Vasc. Anesth. 18(1), 1-6 (2004).
2. Goei D, Hoeks SE, Boersma E et al. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coronary Artery Dis. 20(3), 219-224 (2009).
3. Landesberg G, Shatz V, Akopnik I et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J. Am. Coll. Cardiol. 42(9), 1547-1554 (2003).
4. Levy M, Heels-Ansdell D, Hiralal R et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 114(4), 796-806 (2011).
5. Padayachee L, Rodseth RN, Biccard BM. A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 64(4), 416-424 (2009).
6. Redfern G, Rodseth RN, Biccard BM. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia 66(7), 604-610 (2011).
7. Rodseth RN, Lurati Buse GA, Bolliger D et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J. Am. Coll. Cardiol. 58(5), 522-529 (2011).
8. Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 111(2), 311-319 (2009).
9. Weber T, Auer J, Eber B. The diagnostic and prognostic value of brain natriuretic peptide and aminoterminal (nt)-pro brain natriuretic peptide. Curr. Pharm. Des. 11(4), 511-525 (2005).
10. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90(1), 195-203 (1994).
11. Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J. Am. Coll. Cardiol. 50(17), e159-e241 (2007).
12. Back MR, Schmacht DC, Bowser AN et al. Critical appraisal of cardiac risk stratification before elective vascular surgery. Vasc. Endovasc. Surg. 37(6), 387-397 (2003).
13. Bursi F, Babuin L, Barbieri A et al. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. Eur. Heart J. 26(22), 2448-2456 (2005).
14. Gilbert K, Larocque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann. Intern. Med. 133(5), 356-359 (2000).
15. Heinisch RH, Barbieri CF, Nunes Filho JR, Oliveira GL, Heinisch LM. Prospective assessment of different indices of cardiac risk for patients undergoing noncardiac surgeries. Arq. Bras. Cardiol. 79(4), 327-338 (2002).
16. Kumar R, Mckinney WP, Raj G et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J. Gen. Intern. Med. 16(8), 507-518 (2001).
17. Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann. Intern. Med. 152(1), 26-35 (2010).
18. Choi JH, Cho DK, Song YB et al. Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery. Heart 96(1), 56-62 (2010).
19. Fellahi JL, Hanouz JL, Le Manach Y et al. Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery. Anesthesiology 111(2), 250-257 (2009).
20. Bakker EJ, Ravensbergen NJ, Poldermans D. Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Curr. Opin. Crit. Care 17(5), 409-415 (2011).
21. Goei D, Van Kuijk JP, Flu WJ et al. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery. Am. J. Cardiol. 107(4), 609-614 (2011).
22. Daniels JS, Pourmand N. Label-free impedance biosensors: opportunities and challenges. Electroanalysis 19(12), 1239-1257 (2007).
23. Newman JD, Setford SJ. Enzymatic biosensors. Mol. Biotechnol. 32(3), 249-268 (2006).
24. Davis F, Nabok AV, Higson SPJ. Species differentiation by DNA-modified carbon electrodes using an ac impedimetric approach. Biosens. Bioelectron. 20(8), 1531-1538 (2005).
25. Lisdat F, Schafer D. The use of electrochemical impedance spectroscopy for biosensing. Anal. Bioanal. Chem. 391(5), 1555-1567 (2008).
26. La Belle JT, Gerlach JQ, Svarovsky S, Joshi L. Label-free impedimetric detection of glycan-lectin interactions. Anal. Chem. 79(18), 6959-6964 (2007).
27. Bothara M, Venkatraman V, Reddy RK, Barrett T, Carruthers J, Prasad S. Nanomonitors: electrical immunoassays for protein biomarker profiling. Nanomedicine 3(4), 423-436 (2008).
28. Nagaraj VJ, Aithal S, Eaton S, Bothara M, Wiktor P, Prasad S. NanoMonitor: a miniature electronic biosensor for glycan biomarker detection. Nanomedicine 5(3), 369-378 (2010).
29. Reddy RK, Bothara MG, Barrett TW, Carruthers J, Prasad S. Nanomonitors: Protein biosensors for rapid analyte analysis. Sensors J. IEEE 8(6), 720-723 (2008).
30. Yang W, Butler JE, Russell JN, Robert J Jr, Hamers RJ. Direct electrical detection of antigen-antibody binding on diamond and silicon substrates using electrical impedance spectroscopy. Analyst 132, 296-306 (2007).
31. Reddy RKK, Prasad S, Barrett TW, Carruthers J. Electrical immunoassays toward clinical diagnostics: identification of vulnerable cardiovascular plaque. J. Assoc. Lab. Auto 13(1), 33-39 (2008).
32. Katz E, Itamar Willner I. Probing biomolecular interactions at conductive and semiconductive surfaces by impedance spectroscopy: routes to impedimetric immunosensors, DNA-sensors, and enzyme biosensors Electroanalysis 15(11), 913-947 (2003).
33. Pei R, Cheng Z, Wang E, Yang X. Amplification of antigen-antibody interactions based on biotin labeled protein-streptavidin network complex using impedance spectroscopy. Biosens. Bioelectron. 16(6), 355-361 (2001).
34. Collins J, Lee AP. Microfluidic flow transducer based on the measurement of electrical admittance. Lab Chip 7-10 (2004).
35. Balamurugan S, Obubuafo A, Soper SA, Spivak DA. Surface immobilization methods for aptamer diagnostic applications Anal. Bioanal. Chem. 390(4), 1009-1021 (2007).
36. Riepla M, Mirskya VM, Novotnyb I, Tvarozekb V, Rehacekb V, Wolfbeisa OS. Optimization of capacitive affinity sensors: drift suppression and signal amplification. Anal. Chim. Acta 392(1), 77-84 (1999).
37. Zhang L, Wei Q, Mao L, Liu W, Mills GB, Coombes K. Serial dilution curve: a new method for analysis of reverse phase protein array data. Bioinformatics 25(5), 650-654 (2009).
38. NCCLS. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. NCCLS document EP9-A2 (ISBN 1-56238-472-4) (2002).